NEW YORK (Reuters Health) - A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with more than a two-fold increased risk of prostate cancer, earlier disease onset, and prostate cancer with more aggressive features.
“Consideration should be made to classify this group of individuals as ‘high risk’, just like men of African-American heritage and men with a family history of prostate cancer,” Dr. Karim Chamie, from the University of California Davis, Sacramento, and colleagues recommend.
Read the rest of this entry »
January 4th, 2009 | Posted in Prostate Cancer | Tags: Agent, cancer, exposure, Linked, Orange, Prostate
Cell Genesys Inc. shares dropped sharply today as the South San Francisco company said it will cut more than 200 jobs, is exploring its sale or liquidation, and stopping the late-stage trial of its prostate cancer drug.
The company (NASDAQ: CEGE) also said it was terminating the employment of Chief Medical Officer Robert Dow.
Cell Genesys shares were down 45 cents — or 73 percent — to 17 cents per share in mid-day trading.
Read the rest of this entry »
January 4th, 2009 | Posted in News, Prostate Cancer | Tags: cancer, Cell, explores, Genesys, Prostate, sale, stops, trial
The National Cancer Institute has announced its decision to suspend a study on the benefits of vitamin E and selenium supplements treatments on prostate cancer prevention. The study, called SELECT (Selenium and vitamin E Cancer Prevention Trial), involved more than 35,000 men and was conducted at 400 sites around the United States.
Researchers found a higher risk for aggressive prostate cancer in participants taking only vitamin E and a small increased risk of developing diabetes in subjects taking only selenium. The researchers cautioned that those effects may have been due to chance and they were not statistically significant.
Read the rest of this entry »
January 4th, 2009 | Posted in Lung Cancer, News, Pancreatic Cancer, Prostate Cancer | Tags: cancer, Prostate, Reduce, risk, Selenium, Vitamin